Home > H3D News > News

News

Current news articles are found here.

19th RSC/ SCI MEDICINAL CHEMISTRY SYMPOSIUM
Friday, October 6, 2017 - 18:00

MedChemNet and Infectious Diseases Hub were absolutely delighted to attend the first two days of the recent 19th RSC / SCI Medicinal Chemistry Symposium – Europe’s premier biennial Medicinal Chemistry event – focusing on first disclosures of significant new therapeutic agents across all disease areas and new strategies in medicinal chemistry.

FIGHTING MALARIA IN THE LAB
Friday, October 6, 2017 - 18:00

Kelly Chibale, Professor of Organic Chemistry at Cape Town University in South Africa, talks about his drug discovery work and coming up with compounds that might have an impact on malaria control and elimination

YouTube Link

FIVE QUESTIONS WITH PROF. KELLY CHIBALE
Friday, October 6, 2017 - 18:00

This week, we were fortunate to catch up with Professor Kelly Chibale, Principal Investigator at the University of Cape Town, founder of Africa’s first drug discovery and development centre, H3D, and one of the speakers at our #ScienceAfrica UnConference this year. Professor Chibale spoke eloquently about his efforts to create novel medicines to combat the major diseases in Africa as well as his concerted advocacy for greater investment in hard scientific infrastructure.

Mosquito biting a human finger
COMMUNITY OF PRACTICE IN MALARIA ELIMINATION HOSTED AT UP
Friday, August 4, 2017 - 18:00

The University of Pretoria (UP) will host its first Community of Practice (CoP) focusing specifically on Malaria Elimination in the UP Institute for Sustainable Malaria Control (UP ISMC). This NRF initiative endeavours to provide ‘vehicles to enable the implementation of integrated trans-disciplinary and multi-disciplinary solutions to address societal challenges and to ultimately bring change to the lives of South Africans.

Dr Mathew Njoroge (H3D), in laboratory
NJOROGE TAKES NOTES FROM LAUREATES IN LINDAU
Friday, August 4, 2017 - 18:00

Postdoctoral research fellow Dr Mathew Njoroge at UCT’s Drug Discovery and Development Centre (H3D) recently returned from the 67th Lindau Nobel Laureate Meeting in Germany. The annual scientific conferences have been held in Lindau since 1951, bringing together Nobel laureates and young scientists to foster scientific exchanges between different generations and cultures.

SA MUST BUILD A SCIENCE INDUSTRY
Friday, August 4, 2017 - 18:00

There is a great need to fund talented African scientists — based in Africa — to succeed, rather than just survive, by providing world-class infrastructure. The continent is also facing a lack of scientific entrepreneurship and poorly developed scientific networks between different groups.

CALL FOR MORE INVESTMENT IN SCIENCE INFRASTRUCTURE IN AFRICA
Tuesday, July 25, 2017 - 18:00

Researcher Professor Kelly Chibale has called for a deep commitment to investing in world-class infrastructure and skills for scientists to succeed on the continent.

INVEST IN SCIENCE JOBS FOR AFRICA
Friday, July 21, 2017 - 18:00

Leading African researcher Professor Kelly Chibale has called for a deep commitment to investing in world-class infrastructure and skills to enable scientists to succeed on the continent..

Picture: THINKSTOCK
DRUGS SECTOR TIE-UPS 'CAN HELP CURE SA'
Friday, May 19, 2017 - 18:00

Production of drugs in SA instead of outsourcing to countries such as India would dent high unemployment.

Public-private partnerships in the pharmaceutical sector are vital for accelerating job creation and infrastructure development in SA, says malaria researcher Kelly Chibale.

Anopheles gambiae obtaining a blood meal from a human host. Photo Jim Gathany via Flickr.
NEW ANTIMALARIAL DRUG SHOWS PROMISE
Wednesday, April 26, 2017 - 18:00

An exciting new antimalarial drug candidate is active across the entire parasite life cycle and holds great promise as a single-dose cure.

A new paper published today in the prestigious journal Science Translational Medicine describes the discovery and biological profiling of an exciting new antimalarial clinical drug candidate. MMV390048 is effective against resistant strains of the malaria parasite and across the entire parasite life cycle, and it has the potential to cure and protect in a single dose.

Professor Kelly Chibale, the director of Africa's first integrated drug discovery and development center, H3D, at his laboratory at the University of Cape Town. Credit: Michael Hammond
NEW PUBLICATION HIGHLIGHTS THE ANTI-MALARIAL EFFICACY OF EXCITING NEW CLINICAL CANDIDATE
Wednesday, April 26, 2017 - 18:00

A new paper published today in the prestigious journal Science Translational Medicine describes the discovery and biological profiling of an exciting new anti-malarial clinical drug candidate, MMV390048, effective against resistant strains of the malaria parasite, and across the entire parasite lifecycle, with the potential to cure and protect in a single dose. The research was conducted by the University of Cape Town (UCT)'s Drug Discovery and Development Centre, H3D, and Medicines for Malaria Venture (MMV), in collaboration with a team of international researchers.
 

Prof Chibale in lab
BEAUTIFUL NEWS
Wednesday, April 26, 2017 - 17:00

Click here to watch the Beautiful News video  

The scientist poised to save millions from the devastation of malaria

Africa has been at the mercy of Malaria for thousands of years. Killing half a million people on the continent each year, the disease is yet to meet its equal. But this could soon change. A team of young scientists at UCT has uncovered a compound that has the potential to attack Malaria at all three stages of its cycle through the human body, with a force beyond anything in modern medicine.

 

Pages